A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment (anakinra), underscoring ...
Since 2022, the hospital has not been providing the life-saving, clot-dissolving TPA drug and instead sending stroke patients to PGI, losing precious time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results